Neonate patients with metabolic disorder show encephalopathy and seizures that may lead to morbidity and mortality. Thus rapid detection and treatment of these patients is necessary. Although Amplitude-integrated electroencephalography (aEEG) has been used for more than a decade in the evaluation of infants with encephalopathy but has not been used in the assessment of neonates suffering from metabolic disorders. In this study, we tried to determine the efficacy of aEEG as an easily available diagnostic tool in the diagnosis of neonates with metabolic diseases.
All cases which admitted to the Neonatal Intensive Care Unit (NICU) of the Children’s Medical Center during a one-year period were enrolled. aEEG recordings were obtained by installing 4 electrodes on the infant’s head by a trained nurse and aEEG was recorded for at least 24 h with a description of the whole tracing. Clinical information, final outcome and questionnaires, including patient information: symptoms of the disease, gender, age, duration of hospitalization and the type of the metabolic disease were recorded in details. The obtained data was analyzed with the Spss24 software.
Only 3 (two girl and one boy) out of 29 aEEGs recordings were abnormal; other patients showed normal aEEGs. The most common clinical and neurological manifestations were seizure (34.5%), hypotonia (31%), and mortality rate was 10.3%. There was no significant correlation between aEEG findings and gender, age, type of disease, laboratory tests findings and positive family history.
Although it has been shown that EEG has a diagnostic value in metabolic diseases, there has been no study on the efficacy of aEEG to evaluate neonates with metabolic diseases. But good accessibility and easy of working with aEEG, promote a tendency to use this procedure as screening tool for metabolic diseases.
The current study about aEEG monitoring in these patients, while limited, can be used as a pilot study for further research on this topic.
Therefore, a correct judgment in this field requires administration of aEEG on a larger population of neonates with metabolic diseases.
Pourfarzam M, Zadhoush F. Newborn screening for inherited metabolic disorders; news and views. J Res Med Sci. 2013;18:801. PubMedCentral
Lin C. EEG manifestations in metabolic encephalopathy. Acta Neurol Taiwanica. 2005;14:151.
Yu JY, Pearl PL. Metabolic causes of epileptic encephalopathy. Epilepsy Res Treat. 2013;2013:124934. CrossRef
Faigle R, Sutter R, Kaplan PW. Electroencephalography of encephalopathy in patients with endocrine and metabolic disorders. J Clin Neurophysiol. 2013;30:505–516. https://doi.org/10.1097/WNP.0b013e3182a73db9, http://www.ncbi.nlm.nih.gov/pubmed/24084183. CrossRef
Demir AB, Bora I, Kaygili E, Ocakoglu G. The assessment of basic features of electroencephalography in metabolic encephalopathies. J Neurol Res. 2014;4:101–9.
Theda C. Use of amplitude integrated electroencephalography (aEEG) in patients with inborn errors of metabolism - a new tool for the metabolic geneticist. Mol Genet Metab. 2010;100 Suppl 1:S42–S48. https://doi.org/10.1016/j.ymgme.2010.02.013, http://www.ncbi.nlm.nih.gov/pubmed/20303809. CrossRef
Sanchez Fernandez I, Loddenkemper T. aEEG and cEEG: two complementary techniques to assess seizures and encephalopathy in neonates: editorial on “amplitude-integrated EEG for detection of neonatal seizures: a systematic review” by Rakshasbhuvankar et al. Seizure. 2015;33:88–89. https://doi.org/10.1016/j.seizure.2015.10.010, http://www.ncbi.nlm.nih.gov/pubmed/26560180. CrossRef
Lavery S, Shah DK, Filan PM, Doyle LW, Inder TE. Single versus bihemispheric amplitude-integrated electroencephalography in relation to cerebral injury and outcome in the term encephalopathic infant. J Paediatr Child Health. 2008;44(5):285–90. CrossRef
Spitzmiller RE, Phillips T, Meinzen-Derr J, Hoath SB. Amplitude-integrated EEG is useful in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischemic encephalopathy: a meta-analysis. J Child Neurol. 2007;22:1069–1078. https://doi.org/10.1177/0883073807306258, http://www.ncbi.nlm.nih.gov/pubmed/17890403. CrossRef
Whitelaw A, Bridges S, Leaf A, Evans D. Emergency treatment of neonatal hyperammonaemic coma with mild systemic hypothermia. Lancet. 2001;358:36–38. https://doi.org/10.1016/S0140-6736(00)05269-7, http://www.ncbi.nlm.nih.gov/pubmed/11454378. CrossRef
Olischar M, Theda C, Lavery S, Coleman L, Hunt RW. Amplitude-integrated EEG abnormalities in two neonates with encephalopathy due to mitochondrial dysfunction (respiratory chain complex I deficiency). J Pediatr Neurol. 2009;7:285–92. CrossRef
Olischar M, Shany E, Aygun C, Azzopardi D, Hunt RW, Toet MC, et al. Amplitude-integrated electroencephalography in newborns with inborn errors of metabolism. Neonatology. 2012;102:203–211. https://doi.org/10.1159/000339567, http://www.ncbi.nlm.nih.gov/pubmed/22797054. CrossRef
Glass HC. Advancing neurologic care in the intensive care nursery. NeoReviews. 2015;16:e519–e25. CrossRef
Kliegman RM, Behrman RE, Jenson HB, Stanton BM. Nelson textbook of pediatrics e-book: Elsevier Health Sciences; 2007.
Lu WY, Chen JY, Chang CF, Weng WC, Lee WT, Shieh JS. Multiscale entropy of electroencephalogram as a potential predictor for the prognosis of neonatal seizures. PLoS One. 2015;10:e0144732. https://doi.org/10.1371/journal.pone.0144732, http://www.ncbi.nlm.nih.gov/pubmed/26658680. CrossRef
Sisman J, Campbell DE, Brion LP. Amplitude-integrated EEG in preterm infants: maturation of background pattern and amplitude voltage with postmenstrual age and gestational age. J Perinatol. 2005;25:391–396. https://doi.org/10.1038/sj.jp.7211291, http://www.ncbi.nlm.nih.gov/pubmed/15815708. CrossRef
- Evaluation of the efficacy of amplitude-integrated electroencephalography in the screening of newborns with metabolic disorder admitted to the NICU
Reza Shervin Badoo
Saeed Jedari Attari
Elahe Movahedi Moghadam
- BioMed Central
Neu im Fachgebiet Radiologie
Meistgelesene Bücher aus der Radiologie
Mail Icon II